NOVAVAX INC revenue breakdown overview

NOVAVAX INC revenue for the last year amounted to 828.22 M CHF, the most of which — 447.40 M CHF — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 1.44 B CHF. The greatest contribution to the revenue figure was made by Europe — last year it brought NOVAVAX INC 225.94 M CHF, and the year before that — 761.55 M CHF.